Research Summaries

Research Summary
Research Summary
02/09/2026
Anthony Calabro, MA
A type III hybrid effectiveness–implementation trial compared community-based organization versus direct-to-consumer delivery of the Keep It Up! digital HIV prevention intervention for young men who have...
02/09/2026
research summary
research summary
11/08/2025
Anthony Calabro, MA
A cross-sectional study of more than 2000 transgender, nonbinary, and gender-diverse adults found 44% had undergone gender-affirming surgery, 82% reported high satisfaction, and 94% faced barriers, most...
11/08/2025
Research Summary
Research Summary
07/30/2025
Kate Young
A multicenter randomized trial has demonstrated that the NeuroSAFE technique significantly improves erectile function and accelerates early urinary continence recovery following robot-assisted radical...
07/30/2025
Conference Coverage
Conference Coverage
07/16/2025
Anthony Calabro, MA
Obstructive sleep apnea (OSA) is more prevalent and complex than often recognized—especially in women, older adults, and patients with comorbid conditions, according to Julianne Blythe, MPA, PA-C, RPSGT, a...
07/16/2025
Research Summary
Research Summary
07/16/2025
Anthony Calabro, MA
In a recent study, most patients who initiated urate-lowering therapy could achieve a patient-acceptable symptom state or low disease activity within 6 to12 months, with lower flare burden associated with...
07/16/2025
Conference Coverage
Conference Coverage
07/12/2025
Kate Young
A nationwide analysis of over 1.4 million hospitalizations of patients with diabetic ketoacidosis revealed gender-based differences in cardiovascular outcomes. Men had higher rates of mortality and...
07/12/2025
Research Summary
Research Summary
06/11/2025
Kate Young
A new national analysis reveals that young adult women (ages 18-25) now binge drink at higher rates than men within the same age range, a reversal of previous trends. While heavy drinking remains more...
06/11/2025
FDA Alert
FDA Alert
06/04/2025
Kate Young
The FDA announced the approval of darolutamide for treating metastatic castration-sensitive prostate cancer. This review was conducted under Project Orbis, which allows for concurrent submission and review...
06/04/2025
Research Summary
Research Summary
02/19/2025
Kate Young
Darolutamide monotherapy reduced prostate-specific antigen response in patients with hormone-sensitive prostate cancer while maintaining testosterone levels in a recent 24-week randomized study.
02/19/2025
Research Summary
Research Summary
01/02/2025
Miranda Manier, BA
A new retrospective study examines treatment trends among men with limited life expectancy diagnosed with prostate cancer in the Veterans Affairs health system from 2000 to 2019. Researchers explored...
01/02/2025